Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Intangibles (2020 - 2025)

Historic Intangibles for Mereo BioPharma (MREO) over the last 6 years, with Q3 2025 value amounting to $643000.0.

  • Mereo BioPharma's Intangibles fell 1952.44% to $643000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $643000.0, marking a year-over-year decrease of 1952.44%. This contributed to the annual value of $643000.0 for FY2024, which is 4095.5% down from last year.
  • According to the latest figures from Q3 2025, Mereo BioPharma's Intangibles is $643000.0, which was down 1952.44% from $470000.0 recorded in Q2 2025.
  • In the past 5 years, Mereo BioPharma's Intangibles ranged from a high of $33.1 million in Q4 2021 and a low of $470000.0 during Q2 2025
  • Over the past 5 years, Mereo BioPharma's median Intangibles value was $866000.0 (recorded in 2024), while the average stood at $9.1 million.
  • Per our database at Business Quant, Mereo BioPharma's Intangibles plummeted by 209.15% in 2022 and then crashed by 4572.75% in 2025.
  • Over the past 5 years, Mereo BioPharma's Intangibles (Quarter) stood at $33.1 million in 2021, then dropped by 8.28% to $30.4 million in 2022, then plummeted by 96.41% to $1.1 million in 2023, then tumbled by 40.96% to $643000.0 in 2024, then changed by 0.0% to $643000.0 in 2025.
  • Its Intangibles stands at $643000.0 for Q3 2025, versus $470000.0 for Q2 2025 and $554000.0 for Q1 2025.